Development and characterization of antibodies specific to caspase-3-produced alpha II-spectrin 120 kDa breakdown product: marker for neuronal apoptosis

被引:43
作者
Nath, R
Huggins, M
Glantz, SB
Morrow, JS
McGinnis, K
Nadimpalli, R
Wang, KKW
机构
[1] Warner Lambert Parke Davis, Parke Davis Pharmaceut Res, Dept Neurosci Therapeut, Lab Neurobiochem, Ann Arbor, MI 48105 USA
[2] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
[3] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA
关键词
caspase; excitotoxicity; neuronal death; fodrin; necrosis; apoptosis;
D O I
10.1016/S0197-0186(00)00040-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alpha II-spectrin (alpha-fodrin) is a demonstrated endogenous substrate for caspase-3 in neurons undergoing unscheduled apoptotic death. We have previously identified the caspase cleavage site that yields the distinctive 120 kDa spectrin breakdown product (SBDP120) as (DSLD(1478*)SVEAL). Here, by using a synthetic peptide (NH2-SVEALC) mimicking the neo-N-terminal of SBDP120 as antigen, we report the development of chicken antibodies that specifically recognize the SBDP120 generated by in vitro caspase-3 digestion of bovine alpha-spectrin on Western blot. These anti-SBDP120 antibodies recognize SBDP120 generated by two apoptotic challenges (staurosporine, EGTA) to human neuroblastoma SH-SY5Y cells. Yet they neither react with intact alpha-spectrin nor its other fragments on Western blots. These anti-SBDP120 work equally well in detecting SBDP120 generated in rat cerebellar granule neurons undergoing potassium withdrawal-induced apoptosis. In immunocytochemical studies, these antibodies also specifically stained apoptotic SH-SY5Y or CGN's undergoing apoptosis in a caspase- inhibitor-sensitive manner. These anti-SBDP120s might become powerful markers for apoptotic neurons in various neurological or neurodegenerative conditions in vivo. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:351 / 361
页数:11
相关论文
共 52 条
[1]  
Armstrong RC, 1997, J NEUROSCI, V17, P553
[2]  
BAHR BA, 1995, J PHARMACOL EXP THER, V273, P902
[3]   Ultrastructural morphological changes are not characteristic of apoptotic cell death following focal cerebral ischaemia in the rat [J].
Campagne, MV ;
Gill, R .
NEUROSCIENCE LETTERS, 1996, 213 (02) :111-114
[4]   A cautionary note on the use of the TUNEL stain to determine apoptosis [J].
CharriautMarlangue, C ;
BenAri, Y .
NEUROREPORT, 1995, 7 (01) :61-64
[5]   EARLY ENDONUCLEASE ACTIVATION FOLLOWING REVERSIBLE FOCAL ISCHEMIA IN THE RAT-BRAIN [J].
CHARRIAUTMARLANGUE, C ;
MARGAILL, I ;
PLOTKINE, M ;
BENARI, Y .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1995, 15 (03) :385-388
[6]  
Chen J, 1997, J NEUROCHEM, V69, P232
[7]   A POTENTIAL ROLE FOR APOPTOSIS IN NEURODEGENERATION AND ALZHEIMERS-DISEASE [J].
COTMAN, CW ;
ANDERSON, AJ .
MOLECULAR NEUROBIOLOGY, 1995, 10 (01) :19-45
[8]  
DELCOSTE MC, 1992, NEUROSCIENCE, V18, P558
[9]   GLUTAMATE-INDUCED NEURONAL DEATH IS NOT A PROGRAMMED CELL-DEATH IN CEREBELLAR CULTURE [J].
DESSI, F ;
CHARRIAUTMARLANGUE, C ;
KHRESTCHATISKY, M ;
BENARI, Y .
JOURNAL OF NEUROCHEMISTRY, 1993, 60 (05) :1953-1955
[10]   P-1 ASPARTATE-BASED PEPTIDE ALPHA-((2,6-DICHLOROBENZOYL)OXY)METHYL KETONES AS POTENT TIME-DEPENDENT INHIBITORS OF INTERLEUKIN-1-BETA-CONVERTING ENZYME [J].
DOLLE, RE ;
HOYER, D ;
PRASAD, CVC ;
SCHMIDT, SJ ;
HELASZEK, CT ;
MILLER, RE ;
ATOR, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (05) :563-564